Makoto Ishigami

Makoto Ishigami, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceutical innovations. With a total of 12 patents to his name, he has focused on creating advancements that enhance the efficacy and stability of drug substances, particularly in the realm of aripiprazole.

Latest Patents

Among his recent innovations is the patent for "Low hygroscopic aripiprazole drug substance and processes for the preparation thereof". This groundbreaking invention presents low hygroscopic forms of aripiprazole, ensuring that the medicinal preparations maintain their solubility and do not convert to a hydrate, even during prolonged storage. This enhancement plays a crucial role in improving the reliability of pharmaceutical products.

Career Highlights

Throughout his career, Makoto Ishigami has worked with notable companies in the pharmaceutical industry, most prominently with Otsuka Pharmaceutical Company, Limited and Otsuka Pharmaceutical Co. Ltd. His work has exemplified a commitment to pioneering advancements in medicines that address the needs of healthcare providers and patients alike.

Collaborations

Collaboration has been an essential aspect of Ishigami's journey as an inventor. He has worked alongside esteemed colleagues, including Takuji Bando and Satoshi Aoki, contributing to a collaborative environment that fosters innovation and the development of cutting-edge pharmaceutical solutions.

Conclusion

Makoto Ishigami's inventive spirit and dedication to innovation have significantly impacted the pharmaceutical industry. His patents, particularly in the development of low hygroscopic forms of aripiprazole, showcase his ability to enhance the properties of drug substances while ensuring their long-term viability. As he continues to push the boundaries of pharmaceutical advancements, Ishigami remains a key figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.